Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001203166 | SCV001374317 | pathogenic | not provided | 2023-12-31 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 5 of the CDH23 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CDH23 are known to be pathogenic (PMID: 11138009, 21940737). This variant is present in population databases (rs764824311, gnomAD 0.02%). Disruption of this splice site has been observed in individuals with Usher syndrome (PMID: 12075507, 18429043). ClinVar contains an entry for this variant (Variation ID: 934718). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003473739 | SCV004210650 | pathogenic | Pituitary adenoma 5, multiple types | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001828631 | SCV002086269 | pathogenic | Usher syndrome type 1 | 2020-04-15 | no assertion criteria provided | clinical testing |